The emission of cerium oxide nanoparticles (CeO2 ) in the diesel exhaust, when cerium compounds were used as a diesel engine catalyst to lower the diesel exhaust particles, is a health concern. Our previous studies have shown that CeO2 induced pulmonary inflammation and lung fibrosis. The objective of the present study is to investigate the modification of fibroblast function by CeO2 in relation to fibrosis. Male Sprague Dawley rats were exposed to CeO2 (0.15 to 7 mg/kg) by a single intratracheal instillation and sacrificed at various times post exposure. Alveolar macrophages (AM) were isolated by bronchoalveolar lavage (BAL), and lung fibroblasts were isolated from the lung tissues. The first BAL fluid and AM culture medium obtained after a 24 h incubation time were saved for further analysis. The results show that at 28 days after CeO2 (3.5 mg/kg) exposure, lung fibrosis was evident by increased hydroxyproline content in lung tissues and enhanced Sirius Red staining collagen fibers in the lung. In addition, the presence of stress actin, expressed as alpha-smooth muscle actin (SMA), in fibroblasts was also significantly increased when compared to the control. Lung fibroblasts isolated from CeO2-exposed rats at 28 days post-exposure showed a dose-dependent decrease in proliferation rate using the MTT assay. Treating primary fibroblasts with CeO2 in vitro, did not significantly affect cell proliferation rate; however, when treated with the first BAL fluid collected at 3- or 10-days after CeO2 exposure, significantly increased cell proliferation when compared to the control. In vitro treatment of fibroblasts with TGF-beta1 significantly increased alpha-SMA expression. These results demonstrate that CeO2 induces a dirverse network of mediators that affects fibroblast proliferation and functional changes that may play a role in lung fibrosis. These findings suggest potential health effects of CeO2 exposure.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.